Search results
Biotech's Blockbuster Week: 3 Stocks to Watch
Zacks via Yahoo Finance· 1 year agoThis week, biotech was a standout performer. As of Friday morning, the SPDR S&P Biotech ETF XBI delivered gains of 6.42% versus gains of 1.79%. Last year...
1 Growth Stock With 741% Upside, According to Wall Street
Motley Fool· 1 year agoShares of biotech Novavax (NASDAQ: NVAX) have plunged 91% in the past year as the company has...
7 Biotech Stocks That Will Make You Rich in 10 Years
InvestorPlace via Yahoo Finance· 1 year agoIf you have the patience to go through wild undulations, then you may be a candidate for biotech stocks that will make you rich in 10 years. Even among...
Prediction: This Beaten-Down Stock Will Be a Biotech Giant by 2030
Motley Fool· 10 months agoWhen you think of biotech giants, you may think of Amgen or Biogen. These companies have brought...
Is It Too Late to Buy Novavax Stock?
Motley Fool via Yahoo Finance· 4 months agoA few years ago, biotech company Novavax (NASDAQ: NVAX) looked like a promising stock. It emerged as a leader in the development of a COVID-19 vaccine,...
Zacks Industry Outlook Highlights Gilead Sciences, CRISPR Therapeutics, ACADIA Pharmaceuticals,...
Zacks via Yahoo Finance· 6 months agoFor Immediate Release Chicago, IL – November 24, 2023 – Today, Zacks Equity Research discusses...
How These Biotech Players Could Help Treat Covid-Fueled Depression
Investor's Business Daily· 2 years agoThe "brain health pandemic" since Covid struck exposed a glaring void: Current depression treatments...
2 Top Biotech Stocks to Buy in November
Motley Fool· 2 years agoBiotech giants Regeneron Pharmaceuticals (NASDAQ: REGN) and Gilead Sciences (NASDAQ: GILD) are among them. Eylea could lose patent protection as early as...
Could Novavax Become the Next Moderna?
Motley Fool via Yahoo Finance· 2 weeks agoNovavax (NASDAQ: NVAX) and Moderna (NASDAQ: MRNA) both entered the coronavirus vaccine race around the same time, in early pandemic days, and their...
3 Biotech Stocks That Could Skyrocket in the Next 12 Months
InvestorPlace via Yahoo Finance· 12 months agoNavigating the turbulent waters in the biotech space is no mean feat. With the sector’s inherent...
